CCS
Concentric Capital Strategies’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,960
| Closed | -$1.24M | – | 129 |
|
|
2022
Q4 | $1.24M | Sell |
2,960
-763
| -20% | -$321K | 0.57% | 75 |
|
|
2022
Q3 | $1.55M | Buy |
3,723
+2,123
| +133% | +$886K | 0.55% | 65 |
|
|
2022
Q2 | $792K | Sell |
1,600
-1,800
| -53% | -$891K | 0.6% | 60 |
|
|
2022
Q1 | $1.92M | Buy |
+3,400
| New | +$1.92M | 0.62% | 64 |
|